Phytotherapy in the treatment of depressive states in adolescents

DOI: https://doi.org/10.29296/25877305-2022-09-05
Download full text PDF
Issue: 
9
Year: 
2022

D. Elistratov(1); Professor K. Grigoryev(2), MD
1- «Parafarm», Penza
2-N.I. Pirogov Russian National Research Medical University, Ministry of Health
of Russia, Moscow

Depression among children and adolescents is relatively common but frequently undiagnosed. Early detection of depression in young patients contributes to the efficiency of therapy and to a substantial improvement in quality of life. Combination treatment with psychotherapy and the herbal remedy Hypericum P (Hypericum perforatum) is the safest method for treating children. Hypericum P is designed using Russia’s unique cryopreservation technology. The paper considers the pharmacotherapeutic mechanisms of human exposure to the medicinal plant Hypericum P that is a natural antidepressant and has great potential to treat adolescent mental illness. In addition, the administration of the drug does not cause unwanted reactions.
Keywords: 
therapy
pediatrics
depression
children
antidepressants
phytotherapy
Hypericum P.

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Podol’skii A.I., Idobaeva O.A., Kheimans P. Diagnostika podrostkovoi depressivnosti. Teoriya i praktika. SPb: Piter, 2004; 202 s. (in Russ.).
  2. Ivanova T.I., Pushkareva D.V. Prevalence and symptomatic structure mood disorder of depressive spectrum in schoolchildren the city of Omsk. Omskii psikhiatricheskii zhurnal. 2017; 1 (11): 5–11 (in Russ.).
  3. Kiseleva M.G. Depression in infants and toddlers. National Psychological Journal. 2017; 4: 104–13 (in Russ.). DOI: 10.11621/npj.2017.0410
  4. Gledhill J., Garralda M.E. Sub-syndromal depression in adolescents attending primary care: frequency, clinical features and 6-month outcome. Soc Psychiatry Psychiatr Epidemiol. 2013; 48 (5): 735–44. DOI: 10.1007/s00127-012-0572-z
  5. Dennison M.L The importance of developmental mechanisms in understanding adolescent depression. Soc Psychiatry Psychiatr Epidemiol. 2016; 51 (6): 791–3. DOI: 10.1007/s00127-016-1216-5
  6. Hetrick S.E., McKenzie J.E., Bailey A.P. et al. Newer generation antidepressants for depression in children and adolescents: a network meta-analysis. Cochrane Database Syst Rev. 2021; 5: CD013674. DOI: 10.1002/14651858.CD013674.pub2
  7. Otasowie J., Castells X. Ehimare U.P. et al. Cochrane Database of Systematic Reviews. Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents. Cochrane Database Syst Rev. 2014; 9: CD006997. DOI: 10.1002/14651858.CD006997.pub2.
  8. Mazaeva N.A. Adolescent depressions: a view on the problem (by the foreign publications). Psikhiatriya i psikhofarmakoterapiya. 2017; 19 (3): 25–34 (in Russ.).
  9. Turishchev S. Formirovanie vektora psikhicheskogo komforta fitosredstvami. Vrach. 2008; 3: 43–5 (in Russ.).
  10. Ng Q.X., Venkatanarayanan N., Ho C.Y.X. Clinical use of Hypericum perforatum (St John’s wort) in depression: A meta-analysis. J Affect Disord. 2017; 210: 211–21. DOI: 10.1016/j.jad.2016.12.048
  11. Vorobyeva O.V., Pilipovich A.A., Fateeva V.V. Impact of endothelial inflammation on depression in patients with cerebral microangiopathy: a prospective study. Neurology, Neuropsychiatry, Psychosomatics. 2022; 14 (1): 32–7 (in Russ.). DOI: 10.14412/2074-2711-2022-1-32-37
  12. Mazur M.N. Zveroboi prodyryavlennyi – al’ternativa sovremennym antidepressantam. Vestnik farmatsii. 2001; 3–4: 28–30 (in Russ.).
  13. Golyak Yu.A., Khishova O.M. Razrabotka sostava kapsuly izmel’chennoi travy pustyrnika. Vestnik farmatsii. 2006; 4: 3–10 (in Russ.)